Pricing Log in Create free account
Saturday 17 October 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) Current ratio

Alert me on Current ratio

Charles River Laboratories International, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.3×, up 0.1× from fiscal 2025 (1.3×). Over the past ten years it has ranged from 1.2× (fiscal 2021) to 1.8× (fiscal 2015); the current reading is higher than 18% of that period. That is below the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.3× (8.49%)
FY2024 1.4× (7.43%)
FY2023 1.5× 15.66%
FY2022 1.3× 6.90%
FY2021 1.2× (13.78%)
FY2020 1.4× (0.54%)
FY2019 1.4× (10.59%)
FY2018 1.6× (9.81%)
FY2017 1.8× 16.64%
FY2016 1.5× (14.76%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.3× (1.01%)
Mar 2026 1.4× 5.40%
Dec 2025 1.3× (5.42%)
Sep 2025 1.4× 0.38%
42 more quarters

Against its own ten years

Low 1.2× High 1.8×
Ten-year median 1.4×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
GH Guardant Health, Inc. compare 4.0×
QGEN QIAGEN N.V. compare 2.8×
TWST Twist Bioscience Corporation compare 2.7×
RVTY Revvity Inc. compare 1.8×
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 1.6×
CRL Charles River Laboratories International, Inc. 1.3×
ICLR ICON PLC compare 1.0×
MEDP Medpace Holdings, Inc. compare 0.7×
Diagnostics & Research industry median 2.0×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on CRL